Thromboembolism and bleeding in newly diagnosed Multiple Myeloma – Rates, risk profile and patterns of thromboprophylaxis

Hamostaseologie 2024; 44(S 01): S27-S29
DOI: 10.1055/s-0044-1779097

Abstracts

Topics

T-06. Cancer and thrombosis

L. Vospernik

¹Medical University of Vienna, Department of Medicine 1, Clinical Division of Haematology and Haemostaseology, Vienna, Austria

,

H. Agis

¹Medical University of Vienna, Department of Medicine 1, Clinical Division of Haematology and Haemostaseology, Vienna, Austria

,

C. Ay

¹Medical University of Vienna, Department of Medicine 1, Clinical Division of Haematology and Haemostaseology, Vienna, Austria

,

L. Z. Rüsing

¹Medical University of Vienna, Department of Medicine 1, Clinical Division of Haematology and Haemostaseology, Vienna, Austria

,

H. Gisslinger

¹Medical University of Vienna, Department of Medicine 1, Clinical Division of Haematology and Haemostaseology, Vienna, Austria

,

I. Simonitsch-Klupp

²Medical University of Vienna, Clinical Institute of Pathology, Vienna, Austria

,

M. T. Krauth

¹Medical University of Vienna, Department of Medicine 1, Clinical Division of Haematology and Haemostaseology, Vienna, Austria

,

J. Riedl

¹Medical University of Vienna, Department of Medicine 1, Clinical Division of Haematology and Haemostaseology, Vienna, Austria

References
1 Carrier M, Le Gal G, Tay J, Wu C, Lee AY. 'Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis.'. J Thromb Haemost 2011; 9 (04) 653-663
2 Farge D, Frere C, Connors JM, Khorana AA, Kakkar A, Ay C, Muñoz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-García LA, Bounameaux H, Pabinger I, Douketis J. '2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.'. Lancet Oncol 2022; 23 (07) e334-e347
3 Li A, Wu Q, Luo S, Warnick GS, Zakai NA, Libby EN. et al. 'Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma.'. J Natl Compr Canc Netw 2019; 17 (07) 840-7
4 Sanfilippo KM, Luo S, Wang TF, Fiala M, Schoen M, Wildes TM. et al. 'Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score.'. Am J Hematol 2019; 94 (11) 1176-84
5 Schulman S, Kearon C. 'Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.'. J Thromb Haemost 2005; 3 (04) 692-4